Clinical Trials Browser

Phase 2 × INDUSTRY × MBT-0206 × Clear all

NCT00448305 2012-01-05

EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT00377936 2008-11-14

EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms